Sfoglia per Autore
Risk factor for upper limb deep vein thrombosis
2002 Verso, M.; Agnelli, Giancarlo; Nenci, Giuseppe Giorgio
Prevalence of thrombophilic genetic mutations in patients undergoing thrombotic events while on oral anticoagulants a case-control study
2002 Taliani, R.; Castori, L.; Agnelli, Giancarlo; Nenci, Giuseppe Giorgio; Gresele, Paolo
Interaction beteween thrombophilic genetic mutations and clinical bleeding in patients undergoing chronic oral anticoagulant treatment
2002 Castori, L.; Taliani, R.; Agnelli, Giancarlo; Nenci, Giuseppe Giorgio; Gresele, Paolo
Sulodexide in the treatment of intermittent claudication. Results of a randomized, double-blind, multicentre, placebo-controlled study.
2002 Coccheri, S.; Scondotto, G.; Agnelli, Giancarlo; Palazzini, E.; Zamboni, V.; Arterial Arm of the Suavis, (. A. V. I. S. g.
Perspectives on antithrombotic agents: from unfractionated heparin to new antithrombotics
2002 Agnelli, Giancarlo; Sonaglia, F.
Pathogenesis of venous thromboembolism
2002 Becattini, Cecilia; Agnelli, Giancarlo
Inhibition of fluid phase and clot-bound thrombin by the thrombin exosite I ligand LU 58463: comparison with heparin and hirudin.
2002 Filippucci, E.; Agnelli, Giancarlo; Leone, M.; Nenci, G. G.
Unresolved issues in the prevention and treatment of venous thromboembolism
2002 Agnelli, Giancarlo
Randomised double blind, multicentre, placebo controlled study of sulodexide in the treatment of venous leg ulcers
2002 Coccheri, S.; Secondotto, G.; Agnelli, Giancarlo; Aloisi, D.; Palazzini, E.; Zamboni, V.; Venous arm of the SUAVIS, (. A. V. I. S. G.
Thrombolysis vs heparin in the treatment of pulmonary embolism: a clinical outcme-based meta-analysis
2002 Agnelli, Giancarlo; Becattini, Cecilia; Kirschstein, T.
Duration of prophylaxis against venous thromboembolism with enoxaparin after surgery for cancer
2002 Bergqvist, D.; Agnelli, Giancarlo; Cohen, A.; Eldor, A.; Nilsson, P.; Enoxan II, I.
Preoperative or postoperative start of prophylaxis for venous thromboembolism with low-molecular-weight heparin in elective hip surgery?
2002 Strebel, N.; Prins, M.; Agnelli, Giancarlo; Buller, H.
Direct thrombin inhibitor melagatran followed by oral ximelagatran in comparison with enoxaparin for prevention of venous thromboembolism after totalk hip or knee replacement
2003 Eriksson, B.; Agnelli, Giancarlo; Cohen, A.; Dahl, O.; Mouret, P.; Rosencher, N.; Eskilson, C.; Nylander, I.; Frison, L.; Ogren, M.; METHRO III, S. G.
The direct thrombin inhibitor melagatran followed by oral ximelagatran compared with enoxaparin for the prevention of venous thromboembolism after total hip or knee replacement: the EXPRESS Study.
2003 Eriksson, B.; Agnelli, Giancarlo; Cohen, A.; Dahl, O.; Lassen, M.; Mouret, P.; Rosencher, N.; Kalebo, P.; Panfilov, S.; Eskilson, C.; Andersson, M.; Freij, A.; Express, S. G.
Incidence of cancer after a first episode of idiopathic venous thromboembolism treated with 3 months or 1 year of oral anticoagulation.
2003 Taliani, Mr; Agnelli, Giancarlo; Prandoni, P; Becattini, Cecilia; Moia, M; Bazzan, M; Ageno, W; Tomasi, C; Guazzaloca, G; Ambrosio, Gb; Bertoldi, A; Salvi, R; Poggio, R; Silingardi, M; FOR THE WARFARIN OPTIMAL DURATION ITALIAN TRIAL WODIT, Investigators
The express study: Preliminary results
2003 Eriksson, Bengt; Ansell, Jack; Agnelli, Giancarlo; Dahl, Ola
Complications of chronic venous access devices in cancer patients
2003 Agnelli, Giancarlo
Successful treatment with dermatan sulfate in six patients with heparin-induced thrombocytopenia and acute venous thromboembolism.
2003 Imberti, D; Verso, Melina; Silvestrini, E; Taliani, Mr; Agnelli, Giancarlo
Extended oral anticoagulant therapy after a first episode of pulmonary embolism.
2003 Agnelli, Giancarlo; Prandoni, P; Becattini, Cecilia; Silingardi, M; Taliani, Mr; Miccio, M; Imberti, D; Poggio, R; Ageno, W; Pogliani, E; Porro, F; Zonzin, P; WARFARIN OPTIMAL DURATION ITALIAN TRIAL, Investigators
Critical issues in peripheral arterial disease detection and management: a call to action
2003 Belch, J.; Topol, E.; Agnelli, Giancarlo; Bertrand, M.; Califf, R.; Clement, D.; Creager, M.; Easton, J.; Gavin, J. 3.; Greenland, P.; Hankey, G.; Hanrath, P.; Hirsch, A.; Meyer, J.; Smith, S.; Sullivan, F.; Weber, M.; Prevention of atherothrombotic Disease, N.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Risk factor for upper limb deep vein thrombosis | 2002 | Verso, M.; Agnelli, Giancarlo; Nenci, Giuseppe Giorgio | |
| Prevalence of thrombophilic genetic mutations in patients undergoing thrombotic events while on oral anticoagulants a case-control study | 2002 | Taliani, R.; Castori, L.; Agnelli, Giancarlo; Nenci, Giuseppe Giorgio; Gresele, Paolo | |
| Interaction beteween thrombophilic genetic mutations and clinical bleeding in patients undergoing chronic oral anticoagulant treatment | 2002 | Castori, L.; Taliani, R.; Agnelli, Giancarlo; Nenci, Giuseppe Giorgio; Gresele, Paolo | |
| Sulodexide in the treatment of intermittent claudication. Results of a randomized, double-blind, multicentre, placebo-controlled study. | 2002 | Coccheri, S.; Scondotto, G.; Agnelli, Giancarlo; Palazzini, E.; Zamboni, V.; Arterial Arm of the Suavis, (. A. V. I. S. g. | |
| Perspectives on antithrombotic agents: from unfractionated heparin to new antithrombotics | 2002 | Agnelli, Giancarlo; Sonaglia, F. | |
| Pathogenesis of venous thromboembolism | 2002 | Becattini, Cecilia; Agnelli, Giancarlo | |
| Inhibition of fluid phase and clot-bound thrombin by the thrombin exosite I ligand LU 58463: comparison with heparin and hirudin. | 2002 | Filippucci, E.; Agnelli, Giancarlo; Leone, M.; Nenci, G. G. | |
| Unresolved issues in the prevention and treatment of venous thromboembolism | 2002 | Agnelli, Giancarlo | |
| Randomised double blind, multicentre, placebo controlled study of sulodexide in the treatment of venous leg ulcers | 2002 | Coccheri, S.; Secondotto, G.; Agnelli, Giancarlo; Aloisi, D.; Palazzini, E.; Zamboni, V.; Venous arm of the SUAVIS, (. A. V. I. S. G. | |
| Thrombolysis vs heparin in the treatment of pulmonary embolism: a clinical outcme-based meta-analysis | 2002 | Agnelli, Giancarlo; Becattini, Cecilia; Kirschstein, T. | |
| Duration of prophylaxis against venous thromboembolism with enoxaparin after surgery for cancer | 2002 | Bergqvist, D.; Agnelli, Giancarlo; Cohen, A.; Eldor, A.; Nilsson, P.; Enoxan II, I. | |
| Preoperative or postoperative start of prophylaxis for venous thromboembolism with low-molecular-weight heparin in elective hip surgery? | 2002 | Strebel, N.; Prins, M.; Agnelli, Giancarlo; Buller, H. | |
| Direct thrombin inhibitor melagatran followed by oral ximelagatran in comparison with enoxaparin for prevention of venous thromboembolism after totalk hip or knee replacement | 2003 | Eriksson, B.; Agnelli, Giancarlo; Cohen, A.; Dahl, O.; Mouret, P.; Rosencher, N.; Eskilson, C.; Nylander, I.; Frison, L.; Ogren, M.; METHRO III, S. G. | |
| The direct thrombin inhibitor melagatran followed by oral ximelagatran compared with enoxaparin for the prevention of venous thromboembolism after total hip or knee replacement: the EXPRESS Study. | 2003 | Eriksson, B.; Agnelli, Giancarlo; Cohen, A.; Dahl, O.; Lassen, M.; Mouret, P.; Rosencher, N.; Kalebo, P.; Panfilov, S.; Eskilson, C.; Andersson, M.; Freij, A.; Express, S. G. | |
| Incidence of cancer after a first episode of idiopathic venous thromboembolism treated with 3 months or 1 year of oral anticoagulation. | 2003 | Taliani, Mr; Agnelli, Giancarlo; Prandoni, P; Becattini, Cecilia; Moia, M; Bazzan, M; Ageno, W; Tomasi, C; Guazzaloca, G; Ambrosio, Gb; Bertoldi, A; Salvi, R; Poggio, R; Silingardi, M; FOR THE WARFARIN OPTIMAL DURATION ITALIAN TRIAL WODIT, Investigators | |
| The express study: Preliminary results | 2003 | Eriksson, Bengt; Ansell, Jack; Agnelli, Giancarlo; Dahl, Ola | |
| Complications of chronic venous access devices in cancer patients | 2003 | Agnelli, Giancarlo | |
| Successful treatment with dermatan sulfate in six patients with heparin-induced thrombocytopenia and acute venous thromboembolism. | 2003 | Imberti, D; Verso, Melina; Silvestrini, E; Taliani, Mr; Agnelli, Giancarlo | |
| Extended oral anticoagulant therapy after a first episode of pulmonary embolism. | 2003 | Agnelli, Giancarlo; Prandoni, P; Becattini, Cecilia; Silingardi, M; Taliani, Mr; Miccio, M; Imberti, D; Poggio, R; Ageno, W; Pogliani, E; Porro, F; Zonzin, P; WARFARIN OPTIMAL DURATION ITALIAN TRIAL, Investigators | |
| Critical issues in peripheral arterial disease detection and management: a call to action | 2003 | Belch, J.; Topol, E.; Agnelli, Giancarlo; Bertrand, M.; Califf, R.; Clement, D.; Creager, M.; Easton, J.; Gavin, J. 3.; Greenland, P.; Hankey, G.; Hanrath, P.; Hirsch, A.; Meyer, J.; Smith, S.; Sullivan, F.; Weber, M.; Prevention of atherothrombotic Disease, N. |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile